Fundraising FoxMaaT Pharma
1 known investors
Find your way into MaaT Pharma
Sign up to see every warm intro you have to MaaT Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MaaT Pharma team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MaaT Pharma is a clinical-stage biotech developing microbiome-based therapeutics aimed at improving survival in cancer patients through immune modulation. It operates in the oncology and microbiome therapeutics space.
Investors · 1
Seventure Partnerslisted by Seventure PartnersParis
How we know: Seventure Partners's portfolio page · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountFirst Investment RoundJan 2015Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does MaaT Pharma do?
- MaaT Pharma is a clinical-stage biotech developing microbiome-based therapeutics aimed at improving survival in cancer patients through immune modulation. It operates in the oncology and microbiome therapeutics space.
- Who are MaaT Pharma's investors?
- MaaT Pharma's investors include Seventure Partners.